Share this article


22 March 2017

There is an ever-increasing pressure to reduce costs in a challenged economy. However, a sole focus on the cost of dressings without thought for the total cost for a care ‘episode’ could represent a false economy, failing to consider long-term patient outcomes. Advanced wound dressings can help manage the wound environment, improve healing rates, reduce healing time and long-term disabling outcomes and, therefore, minimise the costs associated with care. This International Making the Case explores PROMOGRAN and PROMOGRAN PRISMA in this context.

Supported by Systagenix, An Acelity Company

Free for all healthcare professionals

Sign up to the Wounds Group journals

By clicking ‘Subscribe’, you are agreeing that the Wounds Group are able to email you periodic newsletters. You may unsubscribe from these at any time. Your info is safe with us and we will never sell or trade your details. For information please review our privacy policy.

Are you a healthcare professional? This website is for healthcare professionals only. To continue, please confirm that you are a healthcare professional below.

We use cookies responsibly to ensure that we give you the best experience on our website. If you continue without changing your browser settings, we’ll assume that you are happy to receive all cookies on this website. Read about how we use cookies.

I am not a healthcare professional.